CoronaryAtlas logo
CoronaryAtlas
Beta-2-glycoprotein I
Pathway / Platelet adhesion & activation

Beta-2-glycoprotein I

APOHprotein

Beta-2-glycoprotein I complexes with oxidized LDL in atherosclerotic lesions and is targeted by antiphospholipid antibodies to activate thrombosis.

Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationaleForms oxLDL complexes; antiphospholipid antibody target in thrombotic syndrome.
Also acts inCoagulation / thrombus, Vascular inflammation, Lipid entry/oxidation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000091583

Type I vs non-Type I discrimination

ScoresNon-Type-I-associated
R — rupture / Type-I
C — non-Type-I
50
A — assay feasibility
68
E — evidence strength
52
T1DI (composite)
12
Specificity differential (R−C)-35
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
2hypovolemia / dehydrationn/a
2tachyarrhythmian/a
2hypoxemia / respiratory failuremag 1
2hypertensive emergencyn/a
2high-demand / peri-operative stressn/a
3sudden cardiac deathn/a
4aPCI-related periproceduraln/a
4bstent thrombosisn/a
4cin-stent restenosisn/a
5CABG-relatedn/a
Coverage: 2/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 2 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(4)